Capnography Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Capnography Device Market By Technology (Side Stream, Main Stream, And Micro Stream), Application (Respiratory Monitoring, Cardiac Care, Trauma And Emergency Care, And Other Applications), End-User (Hospitals, Ambulatory Surgical Centers, And Other End-Users) and geography is expected to grow at a steady CAGR forecast till 2028 owing to the rising prevalence of respiratory disorders and increasing number of surgical procedures across the globe.

The global Capnography Device Market was valued at USD 587 million in 2022, growing at a CAGR of 7.27% during the forecast period from 2023 to 2028. The demand for capnography devices is primarily being boosted by the rising prevalence of respiratory disorders such as respiratory infections, chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. Additionally, the increasing number of surgical procedures across the globe is another factor that is contributing to the growth of the Capnography market during the forecast period from 2023-2028.

Capnography Device Market Dynamics:

As per the study “Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modeling analysis” published in “The Lancet Respiratory Medicine” in 2022 estimated that the prevalence of chronic obstructive pulmonary disease (COPD) was 10.3% in the year 2019, which accounted for around 391.9 million cases, globally. Additionally, the World Health Organization (WHO) 2023, stated that chronic obstructive pulmonary disease became the third leading cause of death as it led to 3.23 million deaths in the year 2019, across the globe. Further, as per the data provided by the World Health Organization 2022, it was estimated that there were around 2.21 million new cases of lung cancer in 2020, globally. Thus, the rising prevalence of respiratory disorders owing to various factors including increasing air pollution, tobacco smoking, and occupational risks, will create a need for the detection and management of respiratory disorders, thus resulting in the positive growth of the Capnography Device market.

Another key driver for the Capnography Device market is the various advantages provided by the Capnography devices over pulse oximeters. The capnography devices provide continuous monitoring of carbon dioxide in the exhaled breath, allowing early detection of respiratory disorders, on the other hand, a pulse oximeter which measures oxygen saturation in the blood, might not be able to detect certain respiratory disorders. Additionally, capnography devices help to assess patients breathing patterns and are capable of detecting airway obstruction. Thus, the various advantages and applications provided by the capnography devices will eventually boost the growth of the Capnography Device market.

However, the high cost associated with the capnography devices and the availability of inexpensive alternatives in the market, are some of the key constraints that may limit the growth of the Capnography Device market.

Capnography Device Market Segment Analysis:

Capnography Device Market by Technology (Side Stream, Main Stream, and Micro Stream), Application (Respiratory Monitoring, Cardiac Care, Trauma and Emergency Care, and Other Applications), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World technology segment of the Capnography Device market, the mainstream category is estimated to amass a significant revenue share in the Capnography Device Market in 2022. This can be attributed to the various advantages provided by Main Steam capnography devices. Mainstream capnography devices provide real-time feedback on the changes in CO2 levels during the respiratory cycle. Additionally, the device offer accurate readings even in dynamic conditions such as varying respiratory rates and tidal volumes, thus providing a reliable assessment of the patient's respiratory status. Therefore, other various advantages provided by the mainstream category such as ease of use, accuracy, and shorter response time are some of the other key factors contributing to the growth of the segment.

Furthermore, as the demand for this segment grows, various novel products are getting regulatory approval from various regulatory organizations across the world. For example, in April 2021, the US FDA provided FDA 510(k) clearance to Radius PCGTM, a portable real-time capnograph with wireless Bluetooth® connectivity.

Therefore, owing to the above-mentioned factors, the mainstream category is expected to register significant growth, thereby driving the growth of the overall Capnography Device market during the forecast period.

North America is expected to dominate the overall Capnography Device Market:

North America is expected to account for the highest proportion of the Capnography Device Market in 2022, out of all regions. This is due to the presence of developed and sophisticated healthcare infrastructure, and the high prevalence of respiratory disorders such as respiratory infections, chronic obstructive pulmonary disease (COPD), asthma, and lung cancer in the region. Additionally, rising technological advancements, presence of major players in the region, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Capnography Device Market in North America.

According to the data provided by the American Society of Cancer 2023, it was estimated that there were around 2,38,340 new cases of lung cancer in the United States in 2023. Additionally, according to the data provided by the Centers for Disease Control and Prevention 2021, it was estimated that around 25 million people in the United States were suffering from asthma in the year 2021. Thus, the rising prevalence of various respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Lung Cancer will create a need for the detection and management of respiratory disorders, thus resulting in the positive growth of the Capnography Device Market in the United States, which will eventually propel the Capnography Device market in North America.

Additionally, the presence of key market players in the region including GE Healthcare, Masimo, Nonin, and Stryker is another contributing factor responsible for the growth of the Capnography Device market in North America.

Further, various key product launches and product approvals in the region are other factors that are influencing the positive growth of the market in North America. For Example, in Septembe 2020, Capsule Technologies received FDA 510(k) clearance approval from the USFDA for its capnography monitoring solution Vitals Plus with the Masimo NomoLine ISA CO2 Module.

Therefore, the factors mentioned above, and the presence of key market players with increasing product launches and product approvals in the region are some of the important factors which are responsible for driving the overall market for Capnography Devices in North America during the forecast period.

Capnography Device Market Key Players:

Some of the key market players operating in the Capnography Device market include Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Drägerwerk AG & Co. KGaA, Infinium Medical, Nonin, TreyMed, Inc., Contec, BD, MEDACX Ltd., Stryker, Hamilton Medical, ICU Medical, Baxter, EDAN Instruments, Inc., GE Healthcare, Zoll Medical Corporation, Avante Health Solutions, and Criticare Technologies, Inc.

Recent Developmental Activities in the Capnography Device Market:

• In June 2022, GE Healthcare and Medtronic entered into a partnership to integrate microstream capnography (CO2) and INVOS regional Oximetry technology to deliver advanced patient monitoring.
• In January 2022, ICU Medical Inc. acquired Smiths Medical. The main objective of the acquisition is to expand ICU Medical's product portfolio.

Key Takeaways from the Capnography Device Market Report Study

• Market size analysis for current Capnography Device Market size (2022), and market forecast for 5 years (2023-2028)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Capnography Device market.
• Various opportunities available for the other competitors in the Capnography Device Market space.
• What are the top-performing segments in 2022? How these segments will perform in 2028?
• Which are the top-performing regions and countries in the current Capnography Device market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Capnography Device market growth in the coming future?

Target Audience who can be benefited from this Capnography Device Market Report Study

• Capnography Device product providers
• Research organizations and consulting companies
• Capnography Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Capnography Device
• Various End-users who want to know more about the Capnography Device Market and the latest technological developments in the Capnography Device Market.

Frequently Asked Questions for the Capnography Device Market:

1. What is meant by Capnography Devices?

Capnography Device also known as a capnograph or capnometer is a medical instrument used to measure the concentration of carbon dioxide (CO2) in the exhaled breath. The device provides a real-time information about the patient's respiratory status, helping healthcare professionals assess ventilation, and detect respiratory abnormalities.

2. What is the market for Capnography Devices?

The global Capnography Device Market was valued at USD 587 million in 2022, growing at a CAGR of 7.27% during the forecast period from 2023 to 2028.

3. What are the drivers for the global Capnography Device market?

The Capnography Device Market is slated to witness prosperity owing to factors such as the growing prevalence of respiratory disorders such as respiratory infections, chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. Additionally, the increasing number of surgical procedures across the globe, are some of the other factors resulting in appreciable revenue growth in the Capnography Device Market during the forecast period (2023-2028).

4. Who are the key players operating in the global Capnography Device market?

Some of the key market players operating in the Capnography Device Market are Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Drägerwerk AG & Co. KGaA, Infinium Medical, Nonin, TreyMed, Inc., Contec, BD, MEDACX Ltd., Stryker, Hamilton Medical, ICU Medical, Baxter, EDAN Instruments, Inc., GE Healthcare, Zoll Medical Corporation, Avante Health Solutions, and Criticare Technologies, Inc.

5. Which region has the highest share in the global Capnography Device market?

North America is expected to dominate the overall Capnography Device Market during the forecast period, 2023 to 2028. This can be attributed to the presence of developed and sophisticated healthcare infrastructure and the high prevalence of respiratory disorders in the region. Additionally, the presence of key market players, rising technological advancement, and a highly potent market in terms of product development, and launches are some of the factors driving the growth of the Capnography Device Market in North America.


This product will be delivered within 2 business days.